Casdin Partners Master Fund, L.P. bought LAB
February 28, 2025 · Form 4 insider transaction
Casdin Partners Master Fund, L.P. bought 545,000 shares of Standard BioTools Inc. at $1.06 per share, a transaction worth $580.4K. The trade was recorded as j and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Represents a cross-trade, pursuant to which Casdin Amplify Fund, LP ("Amplify") transferred 545,000 shares of Common Stock to the Master Fund.; The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the "GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP.